Singh A, Upadhayay S, Mehan S. Inhibition of c-JNK/p38MAPK signaling pathway by Apigenin prevents neurobehavioral and neurochemical defects in ethidium bromide-induced experimental model of multiple sclerosis in rats: Evidence from CSF, blood plasma and brain samples. Phytomedicine Plus. 2021;1(4):100139. https://doi.org/10.1016/j.phyplu.2021.100139.

Article  Google Scholar 

Upadhayay S, Mehan S, Prajapati A, Sethi P, Suri M, Zawawi A, et al. Nrf2/HO-1 signaling stimulation through acetyl-11-keto-beta-boswellic acid (AKBA) provides neuroprotection in ethidium bromide-induced experimental model of multiple sclerosis. Genes. 2022. https://doi.org/10.3390/genes13081324.

Article  PubMed  PubMed Central  Google Scholar 

Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183–93. https://doi.org/10.1016/S1474-4422(14)70256-X.

Article  CAS  PubMed  Google Scholar 

Sharma A, Sharma N, Khanna K, Arora A, Mehan S, Sharma A. Enhancing therapeutic efficacy of fingolimod via intranasal delivery in an ethidium bromide-induced model of multiple sclerosis. J Neurosci Methods. 2025;418(February):110415. https://doi.org/10.1016/j.jneumeth.2025.110415.

Article  CAS  PubMed  Google Scholar 

Prajapati A, Mehan S, Khan Z, Chhabra S, Das Gupta G. Purmorphamine, a Smo-Shh/Gli activator, promotes sonic hedgehog-mediated neurogenesis and restores behavioural and neurochemical deficits in experimental model of multiple sclerosis. Neurochem Res. 2024;49(6):1556–76. https://doi.org/10.1007/s11064-023-04082-9.

Article  CAS  PubMed  Google Scholar 

Khan Z, Gupta GD, Mehan S. Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges. J Clin Med. 2023. https://doi.org/10.3390/jcm12134274.

Article  PubMed  PubMed Central  Google Scholar 

Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O. Seminar Multiple sclerosis. Lancet [Internet]. 2018;6736(18):1–15. https://doi.org/10.1016/S0140-6736(18)30481-1.

Article  Google Scholar 

Shi M, Liu Y, Gong Q, Xu XMultiple sclerosis: an overview of epidemiology, risk factors, and serological biomarkers. Acta Neurol Scand. 2024;2024. https://doi.org/10.1155/2024/7372789.

Houzen H, Kano T, Kondo K, Takahashi T, Niino M. The prevalence and incidence of multiple sclerosis over the past 20 years in northern Japan. Mult Scler Relat Disord. 2023;73(February):104696. https://doi.org/10.1016/j.msard.2023.104696.

Article  PubMed  Google Scholar 

Jia D, Zhang Y, Yang C. The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review. Neurol Sci. 2022. https://doi.org/10.1007/s10072-022-06126-4.

Article  PubMed  PubMed Central  Google Scholar 

Xu L, Chen L, Wang S, et al Urban prevalence of multiple sclerosis in China: A population-based study in six provinces. Eur J Neurol. 2021;28(5):1636–44. https://doi.org/10.1111/ene.14764.

Article  PubMed  Google Scholar 

Correa E, Paredes V, Martínez B Prevalence of multiple sclerosis in Latin America and its relationship with European migration. Mult Scler J Exp Transl Clin. 2016;2:2055217316666407. https://doi.org/10.1177/2055217316666407. Published 2016 Sep 2.

Article  PubMed  PubMed Central  Google Scholar 

Cristiano E, Rojas J, Romano M, et al The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review. Mult Scler. 2013;19(7):844–54. https://doi.org/10.1177/1352458512462918.

Article  CAS  PubMed  Google Scholar 

Khan G, Hashim MJ. Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections. J Epidemiol Glob Health. 2025;15(1):1–11.

Article  Google Scholar 

Walton C, King R, Rechtman L, et al Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler. 2020;26(14):1816–21. https://doi.org/10.1177/1352458520970841.

Article  PubMed  PubMed Central  Google Scholar 

Singhal BS, Advani H Multiple sclerosis in India: An overview. Ann Indian Acad Neurol. 2015;18(Suppl 1):S2–5. https://doi.org/10.4103/0972-2327.164812.

Article  PubMed  PubMed Central  Google Scholar 

Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Heal. 2022;7(2):e105–25.

Article  Google Scholar 

GBD 2016 Neurology Collaborators Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80. https://doi.org/10.1016/S1474-4422(18)30499-X.

Article  Google Scholar 

Kamm CP, Uitdehaag BM, Polman CH Multiple sclerosis: current knowledge and future outlook. Eur Neurol. 2014;72(3–4):132–41. https://doi.org/10.1159/000360528.

Article  CAS  PubMed  Google Scholar 

Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-gould A, Marrie RA, et al. The prevalence of MS in the United States a population-based estimate using health claims data. 2019;0:1029–40.

Voskuhl RR, Sawalha AH, Itoh Y, Program MS, Angeles L, Arbor A. HHS Public Access. 2019;24(1):22–31.

Google Scholar 

Portaccio E, Magyari M, Havrdova K, Ruet A, Brochet B, Scalfari A, et al. Series Multiple Sclerosis 2024 Multiple sclerosis : emerging epidemiological trends and rede fi ning the clinical course. Lancet Reg Heal - Eur [Internet]. 2024;44:100977. https://doi.org/10.1016/j.lanepe.2024.100977.

Article  Google Scholar 

Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, Magliozzi R, et al. Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Ann Neurol. 2018;84(6):829–42.

Article  CAS  PubMed  Google Scholar 

Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, et al. Secondary Progressive Multiple Sclerosis: New Insights. Neurology. 2021;97(8):378–88.

Article  PubMed  PubMed Central  Google Scholar 

Chard DT, Miller DH. What lies beneath grey matter atrophy in multiple sclerosis?. Brain. 2016;139(Pt 1):7–10. https://doi.org/10.1093/brain/awv354.

Vaughn CB, Benedict RHB, Zivadinov R, Weinstock- B. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat Rev Neurol. 2004. https://doi.org/10.1038/s41582-019-0183-3.

Asche CV, Singer ME, Jhaveri M, Chung H, Pharm BS, Miller AAll-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the US. J Managed Care Pharm. 2010;16(9):703–12. https://doi.org/10.18553/jmcp.2010.16.9.703.

Article  Google Scholar 

Dehghani A, Khoramkish M, Shahsavari Isfahani S Challenges in the Daily Living Activities of Patients with Multiple Sclerosis: A Qualitative Content Analysis. Int J Community Based Nurs Midwifery. 2019;7(3):201–10. https://doi.org/10.30476/IJCBNM.2019.44995.

Article  PubMed  PubMed Central  Google Scholar 

Bebo B, Cintina I, LaRocca N, et al The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs. Neurology. 2022;98(18):e1810–7. https://doi.org/10.1212/WNL.0000000000200150.

Article  PubMed  PubMed Central  Google Scholar 

Schauf M, Chinthapatla H, Dimri S, Li E, Hartung DM Economic burden of multiple sclerosis in the United States: A systematic literature review. J Manag Care Spec Pharm. 2023;29(12):1354–68. https://doi.org/10.18553/jmcp.2023.23039.

Article  PubMed  PubMed Central  Google Scholar 

Kobelt G, Thompson A, Berg J, et al New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler. 2017;23(8):1123–36. https://doi.org/10.1177/1352458517694432.

Article  PubMed  PubMed Central  Google Scholar 

Muñoz-galindo IM, Alexander J, Calderón M, Elizabeth N, Téllez G, Orlando H, et al. Health care cost for multiple sclerosis: the case of a health insurer in Colombia. Value Heal Reg Issues. 2018;17(13):14–20. https://doi.org/10.1016/j.vhri.2017.12.001.

Article  Google Scholar 

Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17. https://doi.org/10.1016/S0140-6736(08)61620-7.

Article  CAS  PubMed  Google Scholar 

Lassmann H, Van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Publ Gr. 2012;8(11):647–56. https://doi.org/10.1038/nrneurol.2012.168.

Article  CAS  Google Scholar